Correction to: Enhanced differentiation of human pluripotent stem cells into pancreatic progenitors co-expressing PDX1 and NKX6.1

Correction to: Enhanced differentiation of human pluripotent stem cells into pancreatic progenitors co-expressing PDX1 and NKX6.1 https://doi.org/10.1186/s13287-017-0759-z, published online 23 January 2018.

• The original article contains a number of small errors which the authors would like to clarify:

1. 1)In Fig. 1a of the original article, FGF10 concentration should be 50 ng/ml – as correctly stated in the Methods section – instead of 100 μg/ml.
2. 2)Also in Fig. 1a of the original article, Activin A and EGF concentrations should both be 100 ng/ml – as correctly stated in the Methods section – instead of 100 μg/ml.
3. 3)In the Methods section under the sub-heading “Differentiation of human pluripotent stem cells into pancreatic progenitor”, the term, ‘50 ng/ml hFGF10’ should be omitted from the following sentence:

“At the end of stage 3, media were changed to DMEM supplemented with 1% vol/vol B27, 0.25 mM vitamin C, 50 ng/ml hFGF10, 50 ng/ml hNOGGIN, 100 ng/ml hEGF, and 10 mM nicotinamide (Sigma, USA) for 4 days of stage 4 treatment for each protocol (Fig. 1a).”

FGF10 was only added during stages 2 & 3 of differentiation as correctly depicted in Fig. 1a.

The corrected version of Fig. 1a can be viewed ahead.

The original article has been corrected.

Other Information

Published in: Stem Cell Research & Therapy
License: http://creativecommons.org/licenses/by/4.0/
See article on publisher's website: https://dx.doi.org/10.1186/s13287-018-1002-2